intracoronary stenting


Also found in: Dictionary.

intracoronary stenting

Coronary stenting Cardiology A treatment for vessel closure after percutaneous transluminal coronary angioplasty which ↓ the rate of restenosis, in which a cylindrical stent is placed within vessel(s) that are stenosed by atheroscerotic lesions Complications Thrombotic occlusion of stent, hemorrhage and peripheral vascular complications due to intensive anticoagulation

per·cu·ta·ne·ous co·ro·nar·y in·ter·ven·tion

(PCI) (pĕr'kyū-tā'nē-ŭs kōr'ŏ-nar'ē in'tĕr-ven'shŭn)
The treatment modality used during cardiac catheterization to reduce or remove occlusion within the coronary arteries and increase perfusion to the myocardium. PCIs include atherectomy, brachytherapy, stent implantation, angioplasty, and laser revascularization.
Synonym(s): intracoronary stenting.
References in periodicals archive ?
These results, from a prospective, randomized, controlled trial of high-dose eptifibatide (Integrilin), "clearly demonstrate that GP [glycoprotein] IIb/IIIa inhibitors should become the standard of care for patients undergoing intracoronary stenting," said Dr.
Although PCI and intracoronary stenting are generally successful at restoring blood flow and preventing the collapse of the artery, the deployment of the stent into the artery wall can result in the clumping of blood cells called platelets and the development of an intracoronary thrombus or blood clot.
Food and Drug Administration has approved revised prescribing information for INTEGRILIN(R) to include a new dosing regimen for patients undergoing percutaneous coronary intervention and specific reference within the product's indications for use in patients undergoing intracoronary stenting.
It is also indicated for use at time of PCI, including in patients undergoing intracoronary stenting.
Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance.
Treatment of spontaneous coronary artery dissection with intracoronary stenting.
0015) over the 48 hours following non-urgent balloon angioplasty combined with intracoronary stenting.
These results clearly reinforce our conviction that GP IIb-IIIa inhibitors should be the standard of care for patients undergoing intracoronary stenting," said James E.
amp;uot;The results of this study reinforce our conviction that GP IIb-IIIa inhibitors should be the standard of care for patients undergoing intracoronary stenting.
Recently, Blue Shield of California announced that IVUS services, in conjunction with intracoronary stenting, would be covered.